Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Forkhead box M1 (FoxM1) oncogenic transcription factor represents an attractive therapeutic target in the fight against cancer, because it is overexpressed in a majority of human tumors. Recently, using a cell-based assay system we identified thiazole antibiotic Siomycin A as an inhibitor of FoxM1 transcriptional activity. Here, we report that structurally similar thiazole antibiotic, thiostrepton also inhibits the transcriptional activity of FoxM1. Furthermore, we found that these thiopeptides did not inhibit the transcriptional activity of other members of the Forkhead family or some non-related transcription factors. Further experiments revealed that thiazole antibiotics also inhibit FoxM1 expression, but not the expression of other members of the Forkhead box family. In addition, we found that the thiazole antibiotics efficiently inhibited the growth and induced potent apoptosis in human cancer cell lines of different origin. Thiopeptide-induced apoptosis correlated with the suppression of FoxM1 expression, while overexpression of FoxM1 partially protected cancer cells from the thiazole antibiotic-mediated cell death. These data suggest that Siomycin A and thiostrepton may specifically target FoxM1 to induce apoptosis in cancer cells and FoxM1 inhibitors/thiazole antibiotics could be potentially developed as novel anticancer drugs against human neoplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, Z., Banerjee, S., Kong, D., Li, Y., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1265 · Cited by 245 · cited 1×
“Similarly, suppression of FoxM1 in pancreatic cancer cells by RNA interference led to the inhibition of their metastatic potential [24].”
BackgroundRetractedDiversity of gene expression in adenocarcinoma of the lung
Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,298 · cited 1×
“FoxM1 is overexpressed in hepatocellular carcinomas [13], pancreatic carcinomas [14], breast cancers [15,16], non-small cell lung carcinomas [17], anaplastic astrocytomas and glioblastomas [18], basal cell carcinomas [9] and intrahepatic cholangiocarcinomas [19].”
BackgroundThe emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070 · cited 1×
“Forkhead box M1 (FoxM1) [1], a transcription factor of the Forkhead family [2] is one of the key positive regulators of the cell cycle.”
BackgroundZebrafish Prickle, a Modulator of Noncanonical Wnt/Fz Signaling, Regulates Gastrulation Movements
Veeman, M. T., Slusarski, D. C., Kaykas, A., Louie, S. H., & Moon, R. T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00240-9 · Cited by 945 · cited 1×
“Lef-dependent TOPFlash construct [32]; a gift from Dr.”
BackgroundWang, I.-C., Chen, Y.-J., Hughes, D., Petrovic, V., Major, M. L., Park, H. J., Tan, Y., Ackerson, T., & Costa, R. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10875-10894.2005 · Cited by 627 · cited 1×
“. FoxM1 transcriptionally upregulates target genes involved in cell cycle progression and it is critical for G1/S and G2/M transition, and also for the execution of the mitotic program because FoxM1-depleted cells fail to advance beyond the prophase stage of mitosis”
BackgroundOkabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 603
FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh, M., Wong, S.-T., Neill, G. W., Ghali, L. R., Philpott, M. P., & Quinn, A. (2002) · PubMed · Cited by 397
FoxM1: At the crossroads of ageing and cancer
Laoukili, J., Stahl, M., & Medema, R. H. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.006 · Cited by 377 · cited 3×
“Both the expression and the transcriptional activity of FoxM1 is associated with the proliferative state of cells [1].”
BackgroundYe, H., Kelly, T. F., Samadani, U., Lim, L., Rubio, S., Overdier, D. G., Roebuck, K. A., & Costa, R. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1626 · Cited by 359
Kalinichenko, V. V., Major, M. L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H. M., Dennewitz, M. B., Shin, B., Datta, A., Raychaudhuri, P., et al. (2004) · Genes & Development · doi:10.1101/gad.1200704 · Cited by 356 · cited 2×
“Inhibition of FoxM1 expression by small interfering RNAs [20,21] or by a peptide containing amino acids 24–46 of p19 [22,23] reduced anchorage-independent cell growth in vitro and delayed liver tumor growth in mice.”
Background
Cited by
Nogueira, V., & Hay, N. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1424 · Cited by 514
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors
Halasi, M., Wang, M., Chavan, T. S., Gaponenko, V., Hay, N., & Gartel, A. L. (2013) · Biochemical Journal · doi:10.1042/bj20130282 · Cited by 366
Self-citationThe transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Hegde, N. S., Sanders, D. A., Rodriguez, R., & Balasubramanian, S. (2011) · Nature Chemistry · doi:10.1038/nchem.1114 · Cited by 269
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
Joshi, K., Banasavadi-Siddegowda, Y., Mo, X., Kim, S.-H., Mao, P., Kig, C., Nardini, D., Sobol, R. W., Chow, L. M. L., Kornblum, H. I., et al. (2013) · Stem Cells · doi:10.1002/stem.1358 · Cited by 214
“Downstream target pathways of FOXM1 include VEGF, MMP-2, and -Catenin [9-11], each of which promotes tumor formation and progression.”
BackgroundFoxM1 Is a General Target for Proteasome Inhibitors
Bhat, U. G., Halasi, M., & Gartel, A. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006593 · Cited by 185
“Since FoxM1 suppression appears to inhibit tumorigenesis, chemical compounds that target FoxM1 may act as anticancer drugs [13,14,15,16,17].”
BackgroundMethodSelf-citationNovel functions of FoxM1: from molecular mechanisms to cancer therapy
Alvarez-Fernández, M., & Medema, R. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00030 · Cited by 85
Nicolson, S. C., Li, C., Hirsch, M. L., Setola, V., & Samulski, R. J. (2016) · Journal of Virology · doi:10.1128/jvi.02953-15 · Cited by 48
Sparano, J. A., Goldstein, L. J., Childs, B. H., Shak, S., Brassard, D., Badve, S., Baehner, F. L., Bugarini, R., Rowley, S., Perez, E. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3357 · Cited by 22
“inhibitorsofAuroraKinaseB (36–38),polo-likekinase1 (39, 40), kinesin family member C1, checkpoint kinase 1 (41), and forkhead box M1 (42).”
Metadata
- Authors
- Bhat, U. G., Halasi, M., & Gartel, A. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-05-18
- Volume
- 4
- Issue
- 5
- Pages
- e5592
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2038626783
- Cited by
- 194
- References
- 34
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.